Cardinal Health to Acquire OutcomesMTM

Article

Cardinal Health has announced plans to acquire OutcomesMTM, a privately owned company that contracts with more than 40 US health plans throughout the United States.

PRESS RELEASE

DUBLIN, Ohio, July 16, 2015 — Cardinal Health today announced plans to acquire Des Moines, Iowa-based OutcomesMTM, a privately owned company that contracts with more than 40 U.S. health plans throughout the United States to deliver personalized

Medication Therapy Management

(MTM) services to more than 5.5 million patients through a network of more than 50,000 local chain and independent retail pharmacies, nationwide.

MTM refers to a broad range of health care services, provided by pharmacists, which help ensure patients are on the right medications, using them the right way, and achieving the desired results.

Cardinal Health Pharmaceutical segment CEO Jon Giacomin said that as the healthcare industry continues to evolve toward value-based performance models,

MTM services are becoming an increasingly important tool

in the industry’s effort to improve medication adherence and patient outcomes while reducing adverse events and unnecessary healthcare costs across the continuum of care. He also said that MTM services play a critical role in enabling payers to improve their Medicare Star Ratings performance and other quality improvement measures.

Cardinal Health launched its own

MTM solution for retail pharmacies

in 2014 — through which Cardinal Health pharmacists deliver MTM services to patients, on behalf of participating retail pharmacies. The company also launched an

MTM solution for payers

in 2014, through which the company connects MTM-eligible members with retail pharmacies who can deliver MTM services.

“This acquisition aligns with Cardinal Health’s strategy of getting closer to the patient, by significantly strengthening our ability to help payers, retail pharmacies, hospitals and Integrated Delivery Networks connect their patients, employees and members to pharmacists who can deliver personalized MTM services that can improve care quality and reduce costs,” said Giacomin. “This acquisition also aligns with Cardinal Health’s commitment to helping retail pharmacists receive reimbursement for delivering important cognitive services to patients.”

OutcomesMTM services will be part of Cardinal Health’s Pharmaceutical segment. Its 60+ employees, including its senior management team, will transition to Cardinal Health following the acquisition.

“We sought a partner that shared our vision for MTM along with the resources to advance our program to new heights - we have found that partner in Cardinal Health,” said Tom Halterman, CEO of OutcomesMTM. “We look forward to combining our industry-leading, face-to-face MTM network and technology with Cardinal Health’s broad health care expertise to define a new state-of-the-art for MTM programs.”

Financial details of the acquisition will not be disclosed.

Related Videos
Semaglutide Ozempic injection control blood sugar levels | Image Credit: myskin - stock.adobe.com
Image credit: motortion | stock.adobe.com - Young depressed woman talking to lady psychologist during session, mental health
Image credit:  JPC-PROD | stock.adobe.com - Choosing method of contraception : Birth control pills, an injection syringe, condom, IUD-method, on grey
Semaglutide Ozempic injection control blood sugar levels | Image Credit: myskin - stock.adobe.com
Health care provider examining MRI images of patient with multiple sclerosis -- Image credit: New Africa | stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.